Immunogenicity of a recombinant Mycobacterium bovis bacille Calmette-Guerin expressing malarial and tuberculosis epitopes

被引:11
|
作者
Rapeah, S [1 ]
Norazmi, MN [1 ]
机构
[1] Univ Sains Malaysia, Sch Hlth Sci, Kubang Kerian 16150, Kelantan, Malaysia
关键词
malaria; recombinant BCG; tuberculosis;
D O I
10.1016/j.vaccine.2006.01.053
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Recombinant Mycobacterium bovis bacille Calmette-Guerin (rBCG) expressing the malarial epitopes F2R(II)EBA and (NANP)3 as well as two T cell epitopes of the M. tuberculosis ESAT-6 antigen, generated in favour of mycobacterium codon usage elicited specific immune response against these epitopes. Immunised Balb/c mice demonstrated an increase in almost all of the IgG subclasses against both malarial epitopes and enhanced splenocyte proliferative response against the malarial epitopes as well as selected peptides of ESAT-6. Furthermore, flow cytometric analyses showed elevated numbers of CD4(+) lymphocytes expressing IFN-gamma and IL-2 against the ESAT-6 peptides, suggesting a specific Th1-mediated response. This study demonstrated that expressing malarial and TB epitopes in a single rBCG construct induced appropriate humoral and cellular immune response against immunogenic epitopes from both organisms. (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:3646 / 3653
页数:8
相关论文
共 50 条
  • [21] Expression and immunogenicity of recombinant Mycobacterium bovis Bacillus Calmette-Guerin strains secreting the antigen ESAT-6 from Mycobacterium tuberculosis in mice
    Wang Li-mei
    Shi Chang-hong
    Fan Xiong-lin
    Ying, Xue
    Bai Yin-lai
    Xu Zhi-kai
    CHINESE MEDICAL JOURNAL, 2007, 120 (14) : 1220 - 1225
  • [23] PULMONARY TUBERCULOSIS DUE TO BACILLE CALMETTE-GUERIN
    KIRSTEN, D
    RIEGER, U
    SCHRODER, KH
    BOHLE, A
    MAGNUSSEN, H
    CLINICAL INVESTIGATOR, 1993, 71 (10): : 787 - 790
  • [24] Nicotinamide Limits Replication of Mycobacterium tuberculosis and Bacille Calmette-Guerin Within Macrophages
    Simmons, Jason D.
    Peterson, Glenna J.
    Campo, Monica
    Lohmiller, Jenny
    Skerrett, Shawn J.
    Tunaru, Sorin
    Offermanns, Stefan
    Sherman, David R.
    Hawn, Thomas R.
    JOURNAL OF INFECTIOUS DISEASES, 2020, 221 (06): : 989 - 999
  • [25] Functional characterization of human natural killer cells responding to Mycobacterium bovis bacille Calmette-Guerin
    Esin, S
    Batoni, G
    Pardini, M
    Favilli, F
    Bottai, D
    Maisetta, G
    Florio, W
    Vanacore, R
    Wigzell, H
    Campa, M
    IMMUNOLOGY, 2004, 112 (01) : 143 - 152
  • [26] MYCOBACTERIUM-BOVIS INFECTION OF AN IMPLANTABLE DEFIBRILLATOR FOLLOWING INTRAVESICAL THERAPY WITH BACILLE CALMETTE-GUERIN
    STONE, DR
    ESTES, NAM
    KLEMPNER, MS
    CLINICAL INFECTIOUS DISEASES, 1993, 16 (06) : 825 - 826
  • [27] RECOMBINANT BACILLE CALMETTE-GUERIN PRIMING AGAINST MEASLES
    FENNELLY, GJ
    FLYNN, JL
    TERMEULEN, V
    LIEBERT, UG
    BLOOM, BR
    JOURNAL OF INFECTIOUS DISEASES, 1995, 172 (03): : 698 - 705
  • [28] CLONING AND EXPRESSION OF MALARIA AND TUBERCULOSIS EPITOPES IN MYCOBACTERIUM BOVIS BACILLE CALMETTE-GURIN
    Suppian, Rapeah
    Zainuddin, Zainul Fadziruddin
    Norazmi, Mohd Nor
    MALAYSIAN JOURNAL OF MEDICAL SCIENCES, 2006, 13 (01): : 13 - 20
  • [29] The impact of maternal infection with Mycobacterium tuberculosis on the infant response to bacille Calmette-Guerin immunization
    Mawa, Patrice A.
    Nkurunungi, Gyaviira
    Egesa, Moses
    Webb, Emily L.
    Smith, Steven G.
    Kizindo, Robert
    Akello, Mirriann
    Lule, Swaib A.
    Muwanga, Moses
    Dockrell, Hazel M.
    Cose, Stephen
    Elliott, Alison M.
    PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES, 2015, 370 (1671)
  • [30] Comparative protective effects of recombinant DNA and Mycobacterium bovis bacille Calmette-Guerin vaccines against M-avium infection
    Martin, E
    Triccas, JA
    Kamath, AT
    Winter, N
    Britton, WJ
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2001, 126 (03): : 482 - 487